Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss
Objective: To establish whether there is a possible link between the motor symptoms, which includes RBD in PD patients in this study, who have mild/moderate…Non-motor symptoms in a cross section of PD patients with varying degrees of smell loss
Objective: To establish whether patients with PD who have mild/moderate microsmia, severe microsmia or anosmia (as measured by the University of Pennsylvania Smell Identification Test…Are patients with Parkinson’s disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?
Objective: To investigate the prevalence of loss sense of smell and its possible link with the natural history of PD. Background: Non-motor symptoms (NMS) in…The complex relationship between olfactory and cognitive impairment in Parkinson’s disease
Objective: The aim of our study was to clarify the relationships between olfaction and cognition in Parkinson’s disease (PD) using a comprehensive neuropsychological battery. Background:…Non-motor symptoms in the first neurology consultation in Cali – Colombia
Objective: To describe the distribution of NMS of PD in patients assisted by the Outpatient Neurology Service between 2012 and 2016 in a high level hospital…Effects of deep brain stimulation on olfactory function in Parkinson’s disease
Objective: The aim of this prospective study was to assess the impact of deep brain stimulation (DBS) on olfactory function in Parkinson's disease (PD). Background:…Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease
Objective: We hypothesis that olfactory dysfunction, could be an independent predictor of gait disturbance in early PD. Background: The pathophysiology of gait disturbance is not fully…Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging
Objective: To assess whether any of the biomarkers studied (UPDRS-III, SN echogenicity, UPSIT and DaT-SPECT) in a baseline evaluation of a cohort of LRRK2 G2019S asymptomatic…Clinical characteristics of Parkinson’s disease developed from essential tremor
Objective: The objective of this study is to compare the clinical characteristics of Parkinson’s disease developed from essential tremor (ET-PD) with the clinical characteristics of…Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage
Objective: To evaluate the utility of the combined use of cardiac metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS)…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 15
- Next Page »